Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
2024-09-10 Sale | 2024-09-12 4:30 pm | Crinetics Pharmaceuticals Inc. | CRNX | Betz Stephen F. Chief Scientific Officer | 1,035 | $51.5 | $53,303 | 68,576 (Direct) | View |
2024-08-26 Sale | 2024-08-28 4:31 pm | Crinetics Pharmaceuticals Inc. | CRNX | Betz Stephen F. Chief Scientific Officer | 3,000 | $53.19 | $159,570 | 69,611 (Direct) | View |
2024-08-12 Sale | 2024-08-14 4:30 pm | Crinetics Pharmaceuticals Inc. | CRNX | Betz Stephen F. Chief Scientific Officer | 3,000 | $47.68 | $143,040 | 72,611 (Direct) | View |
2024-07-25 Sale | 2024-07-26 4:38 pm | Crinetics Pharmaceuticals Inc. | CRNX | Betz Stephen F. Chief Scientific Officer | 3,000 | $53.43 | $160,290 | 75,611 (Direct) | View |
2024-07-10 Sale | 2024-07-12 4:30 pm | Crinetics Pharmaceuticals Inc. | CRNX | Betz Stephen F. Chief Scientific Officer | 3,000 | $48.55 | $145,650 | 78,611 (Direct) | View |
2024-06-25 Sale | 2024-06-26 4:32 pm | Crinetics Pharmaceuticals Inc. | CRNX | Betz Stephen F. Chief Scientific Officer | 3,000 | $45.37 | $136,110 | 80,643 (Direct) | View |
2024-06-10 Sale | 2024-06-11 4:35 pm | Crinetics Pharmaceuticals Inc. | CRNX | Betz Stephen F. Chief Scientific Officer | 3,000 | $43.86 | $131,580 | 83,643 (Direct) | View |
2024-05-28 Sale | 2024-05-30 4:28 pm | Crinetics Pharmaceuticals Inc. | CRNX | Betz Stephen F. Chief Scientific Officer | 3,000 | $47.49 | $142,470 | 86,643 (Direct) | View |
2024-05-10 Sale | 2024-05-14 6:29 pm | Crinetics Pharmaceuticals Inc. | CRNX | Betz Stephen F. Chief Scientific Officer | 3,000 | $49.43 | $148,290 | 89,643 (Direct) | View |
2024-01-25 Sale | 2024-01-26 5:50 pm | Crinetics Pharmaceuticals Inc. | CRNX | Betz Stephen F. Chief Scientific Officer | 3,000 | $37.26 | $111,780 | 73,298 (Direct) | View |
2024-01-10 Sale | 2024-01-12 4:12 pm | Crinetics Pharmaceuticals Inc. | CRNX | Betz Stephen F. Chief Scientific Officer | 3,000 | $37.65 | $112,950 | 76,298 (Direct) | View |
2023-12-26 Sale | 2023-12-27 5:20 pm | Crinetics Pharmaceuticals Inc. | CRNX | Betz Stephen F. Chief Scientific Officer | 3,000 | $35.89 | $107,670 | 79,298 (Direct) | View |
2023-12-11 Sale | 2023-12-13 4:44 pm | Crinetics Pharmaceuticals Inc. | CRNX | Betz Stephen F. Chief Scientific Officer | 3,000 | $32.87 | $98,610 | 82,298 (Direct) | View |
2023-11-27 Sale | 2023-11-29 4:31 pm | Crinetics Pharmaceuticals Inc. | CRNX | Betz Stephen F. Chief Scientific Officer | 3,000 | $31.84 | $95,520 | 85,298 (Direct) | View |
2023-02-01 Sale | 2023-02-03 4:30 pm | Crinetics Pharmaceuticals Inc. | CRNX | Betz Stephen F. Chief Scientific Officer | 3,126 | $19.59 | $61,238 | 64,689 (Direct) | View |
2023-01-25 Sale | 2023-01-27 4:26 pm | Crinetics Pharmaceuticals Inc. | CRNX | Betz Stephen F. Chief Scientific Officer | 8,336 | $21.07 | $175,640 | 67,815 (Direct) | View |
2023-01-17 Sale | 2023-01-19 4:28 pm | Crinetics Pharmaceuticals Inc. | CRNX | Betz Stephen F. Chief Scientific Officer | 3,126 | $18 | $56,268 | 76,151 (Direct) | View |
2023-01-03 Sale | 2023-01-05 4:23 pm | Crinetics Pharmaceuticals Inc. | CRNX | Betz Stephen F. Chief Scientific Officer | 3,126 | $18.35 | $57,362 | 79,277 (Direct) | View |
2022-12-15 Sale | 2022-12-19 5:11 pm | Crinetics Pharmaceuticals Inc. | CRNX | Betz Stephen F. Chief Scientific Officer | 3,126 | $16 | $50,016 | 82,403 (Direct) | View |
2022-12-01 Sale | 2022-12-05 5:28 pm | Crinetics Pharmaceuticals Inc. | CRNX | Betz Stephen F. Chief Scientific Officer | 3,126 | $17.84 | $55,768 | 84,968 (Direct) | View |
2022-11-15 Sale | 2022-11-17 4:46 pm | Crinetics Pharmaceuticals Inc. | CRNX | Betz Stephen F. Chief Scientific Officer | 3,126 | $18.72 | $58,519 | 88,094 (Direct) | View |
2022-11-01 Sale | 2022-11-03 4:35 pm | Crinetics Pharmaceuticals Inc. | CRNX | Betz Stephen F. Chief Scientific Officer | 3,126 | $18.52 | $57,894 | 91,220 (Direct) | View |
2022-10-17 Sale | 2022-10-19 5:34 pm | Crinetics Pharmaceuticals Inc. | CRNX | Betz Stephen F. Chief Scientific Officer | 3,126 | $17.73 | $55,424 | 94,346 (Direct) | View |
2022-10-03 Sale | 2022-10-05 4:40 pm | Crinetics Pharmaceuticals Inc. | CRNX | Betz Stephen F. Chief Scientific Officer | 3,126 | $19.64 | $61,395 | 97,472 (Direct) | View |
2022-09-15 Sale | 2022-09-19 4:40 pm | Crinetics Pharmaceuticals Inc. | CRNX | Betz Stephen F. Chief Scientific Officer | 4,168 | $21.01 | $87,570 | 100,598 (Direct) | View |
2022-09-07 Sale | 2022-09-09 4:20 pm | Crinetics Pharmaceuticals Inc. | CRNX | Betz Stephen F. Chief Scientific Officer | 1,042 | $21 | $21,884 | 104,766 (Direct) | View |
2022-09-01 Sale | 2022-09-06 4:20 pm | Crinetics Pharmaceuticals Inc. | CRNX | Betz Stephen F. Chief Scientific Officer | 3,126 | $18.59 | $58,112 | 107,144 (Direct) | View |
2022-05-02 Sale | 2022-05-04 5:01 pm | Crinetics Pharmaceuticals Inc. | CRNX | Betz Stephen F. Chief Scientific Officer | 3,247 | $20.1 | $65,252 | 107,598 (Direct) | View |
2022-04-18 Sale | 2022-04-21 5:00 pm | Crinetics Pharmaceuticals Inc. | CRNX | Betz Stephen F. Chief Scientific Officer | 5,664 | $25.81 | $146,188 | 110,845 (Direct) | View |
2022-04-04 Sale | 2022-04-06 7:08 pm | Crinetics Pharmaceuticals Inc. | CRNX | Betz Stephen F. Chief Scientific Officer | 9,000 | $23.97 | $215,762 | 116,509 (Direct) | View |
2022-03-31 Sale | 2022-04-01 5:39 pm | Crinetics Pharmaceuticals Inc. | CRNX | Betz Stephen F. Chief Scientific Officer | 8,328 | $21.43 | $178,475 | 125,509 (Direct) | View |
2022-03-15 Sale | 2022-03-17 4:33 pm | Crinetics Pharmaceuticals Inc. | CRNX | Betz Stephen F. Chief Scientific Officer | 3,123 | $18.94 | $59,150 | 133,837 (Direct) | View |
2022-03-01 Sale | 2022-03-02 9:00 pm | Crinetics Pharmaceuticals Inc. | CRNX | Betz Stephen F. Chief Scientific Officer | 3,123 | $19.73 | $61,617 | 213,960 (Direct) | View |
2022-02-15 Sale | 2022-02-17 4:34 pm | Crinetics Pharmaceuticals Inc. | CRNX | Betz Stephen F. Chief Scientific Officer | 3,123 | $18.64 | $58,213 | 123,583 (Direct) | View |
2022-02-01 Sale | 2022-02-03 4:30 pm | Crinetics Pharmaceuticals Inc. | CRNX | Betz Stephen F. Chief Scientific Officer | 3,123 | $18.79 | $58,681 | 126,706 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
2024-12-16 Exercise | 2024-12-18 4:30 pm | N/A 2028-03-16 | Crinetics Pharmaceuticals Inc. | CRNX | Betz Stephen F. Chief Scientific Officer | 2,331 | $0 | 251,397 (Direct) | View |
2024-12-16 Exercise | 2024-12-18 4:30 pm | N/A N/A | Crinetics Pharmaceuticals Inc. | CRNX | Betz Stephen F. Chief Scientific Officer | 2,331 | $1.91 | 251,397 (Direct) | View |
2024-03-18 Tax Withholding | 2024-03-20 6:33 pm | N/A N/A | Crinetics Pharmaceuticals Inc. | CRNX | Betz Stephen F. Chief Scientific Officer | 3,655 | $38.14 | 92,643 (Direct) | View |
2024-03-04 Option Award | 2024-03-06 7:57 pm | N/A 2034-03-03 | Crinetics Pharmaceuticals Inc. | CRNX | Betz Stephen F. Chief Scientific Officer | 110,000 | $0 | 183,298 (Direct) | View |
2023-03-16 Tax Withholding | 2023-03-17 5:07 pm | N/A N/A | Crinetics Pharmaceuticals Inc. | CRNX | Betz Stephen F. Chief Scientific Officer | 1,410 | $17.12 | 86,879 (Direct) | View |
2023-03-01 Option Award | 2023-03-03 4:38 pm | N/A 2033-02-28 | Crinetics Pharmaceuticals Inc. | CRNX | Betz Stephen F. Chief Scientific Officer | 133,600 | $0 | 198,289 (Direct) | View |
2022-05-20 Other | 2022-09-06 4:20 pm | N/A N/A | Crinetics Pharmaceuticals Inc. | CRNX | Betz Stephen F. Chief Scientific Officer | 1,336 | $11.02 | 107,144 (Direct) | View |
2022-02-28 Option Award | 2022-03-02 9:00 pm | N/A 2032-02-27 | Crinetics Pharmaceuticals Inc. | CRNX | Betz Stephen F. Chief Scientific Officer | 93,500 | $0 | 213,960 (Direct) | View |